Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
antibiotics
axial spondyloarthritis
bausch health
biogen
biotech
boston blog main
boston top stories
boston university
bots
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
car-t immunotherapy
cell therapy
clinical trials
cluster headache
crispr
deals
detroit blog main
detroit top stories
diagnostics
digital health
dihydroergotamine
dimitry nuyten
drug prices
eddingpharm
eli lilly
elizabeth holmes
fremanezumab
fulcrum therapeutics
gene therapy
What
earlier
2
×
remains
2
×
accurate
aids
approval
bio
biogen’s
biopharmaceutical
cautious
companies
convo
diagnosis
digital
driven
drug
evident
failures
fully
gradually
guest
health
hospitals
issues
littered
medical
mystery
nash
new
news
past
percent
price
prosthetics
providing
remain
repercussions
road
roundup
slow
solutions
Language
Current search:
remains
×
earlier
×
@xconomy.com
4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@venturebeat.com
6 years ago
AI is transforming medical diagnosis, prosthetics, and vision aids
